Loading...
Loading...
DNAY| Name | Value |
|---|---|
| Revenues | 5.7M |
| Cost of Revenue | 2.9M |
| Gross Profit | 2.7M |
| Operating Expense | 17.2M |
| Operating I/L | -14.5M |
| Other Income/Expense | -0.3M |
| Interest Income | 0.0M |
| Pretax | -14.8M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -14.8M |
Codex DNA, Inc. is a synthetic biology company that provides a range of synthetic biology instruments, reagents, and associated products and services to pharmaceutical and academic laboratories worldwide. Its offerings include the BioXp system, BioXp portal, BioXp kits, cloud-based scripts, benchtop reagents, Biofoundry Services, and short oligo ligation assembly enzymatic DNA synthesis. These solutions enable researchers to efficiently create synthetic DNA sequences and assemble them into vectors. The company's customers include pharmaceutical and academic laboratories, government institutions, contract research organizations, and synthetic biology companies.
